Overview
Multi-centre Study of HTL0018318 in Patients as an add-on to Standard-of-care
Status:
Completed
Completed
Trial end date:
2018-07-16
2018-07-16
Target enrollment:
0
0
Participant gender:
All
All
Summary
Multi-centre study of HTL0018318 in patients with Alzheimer's disease as an add-on to standard-of-carePhase:
Phase 1Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Heptares Therapeutics LimitedCollaborator:
Allergan
Criteria
Inclusion Criteria:1. Diagnostic evidence of Alzheimer's disease according to the 2011 National Institutes
of Aging-Alzheimer's Association (NIA-AA) criteria
2. Participants with Alzheimer's disease on stable standard of care
Exclusion Criteria:
1. Presence of illness apart from Alzheimer's disease that could contribute to cognitive
dysfunction
2. A current or history of clinically significant suicidal ideation within the past 6
months
3. Subjects who have been on anti-cholinergic and/or anti muscarinic treatment